Similar articles

Abstract: retinopathy of prematurity (ROP) is a vision-threatening disorder that leads to pathological growth of the retinal vasculature due to hypoxia. Here, we investigated the potential effects of alamandine, a novel heptapeptide in the renin-angiotensin system (RAS), on hypoxia-induced retinal neovascularization and its underlying mechanisms. In vivo, the C57BL/6J mice with oxygen-induced retinopathy (OIR) were injected intravitreally with alamandine (1.0 μmol/kg per eye). In vitro, human retinal microvascular endothelial cells (HRMECs) were utilized to investigate the effects of alamandine (10 μg/mL) on proliferation, apoptosis, migration, and tubular formation under vascular endothelial growth factor (VEGF) stimulation. Single-cell RNA sequencing (scRNA-seq) matrix data from the Gene Expression Omnibus (GEO) database and RAS-related genes from the Molecular Signatures Database (MSigDB) were sourced for subsequent analyses. By integrating scRNA-seq data across multiple species, we identified that RAS-associated endothelial cell populations were highly related to retinal neovascularization. The liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis revealed a significant decrease in alamandine levels in both the serum and retina of OIR mice compared to those in the control group. Next, alamandine ameliorated hypoxia-induced retinal pathological neovascularization and physiologic revascularization in OIR mice. In vitro, alamandine effectively mitigated VEGF-induced proliferation, scratch wound healing, and tube formation of HRMECs primarily by inhibiting the hypoxia-inducible factor-1α (HIF-1α)/VEGF pathway. Further, coincubation with D-Pro⁷ (mas-related G protein-coupled receptor D (MrgD) antagonist) hindered the beneficial impacts of alamandine on hypoxia-induced pathological angiogenesis both in vivo and in vitro. Our findings suggested that alamandine could mitigate retinal neovascularization by targeting the MrgD-mediated HIF-1α/VEGF pathway, providing a potential therapeutic agent for OIR prevention and treatment.

Alamandine通过MrgD介导的HIF-1α/VEGF通路改善病理性视网膜血管新生

[1]AhmedNEMB, MurakamiM, KanekoS, et al., 2016. The effects of hypoxia on the stemness properties of human dental pulp stem cells (DPSCs). Sci Rep, 6:35476.

[2]AmraeiR, RahimiN, 2020. COVID-19, renin-angiotensin system and endothelial dysfunction. Cells, 9(7):1652.

[3]AouissA, Anka IdrissiD, KabineM, et al., 2019. Update of inflammatory proliferative retinopathy: ischemia, hypoxia and angiogenesis. Curr Res Transl Med, 67(2):62-71.

[4]AuNPB, MaCHE, 2022. Neuroinflammation, microglia and implications for retinal ganglion cell survival and axon regeneration in traumatic optic neuropathy. Front Immunol, 13:860070.

[5]BodduSHS, AcharyaD, HalaV, et al., 2023. An update on strategies to deliver protein and peptide drugs to the eye. ACS Omega, 8(39):35470-35498.

[6]BrennerM, MessingA, 2021. Regulation of GFAP expression. ASN Neuro, 13:1759091420981206.

[7]BroxtermanEC, HugDA, 2016. Retinopathy of prematurity: a review of current screening guidelines and treatment options. Mo Med, 113(3):187-190.

[8]ChangE, JosanAS, PurohitR, et al., 2022. A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity. Ophthalmology, 129(12):1389-1401.

[9]ChangRL, LinJW, KuoWW, et al., 2016. Angiotensin-(1–7) attenuated long-term hypoxia-stimulated cardiomyocyte apoptosis by inhibiting HIF-1α nuclear translocation via Mas receptor regulation. Growth Factors, 34(1-2):11-18.

[10]ChecchinD, SennlaubF, LevavasseurE, et al., 2006. Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci, 47(8):3595-3602.

[11]ChengY, ZhangM, XuR, et al., 2024. P53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6. Exp Gerontol, 188:112391.

[12]ChengY, ZhangM, LiCG, et al., 2025. Endothelial AGGF1 promotes retinal angiogenesis by coordinating TNFSF12/FN14 signalling. Nat Commun, 16:1332.

[13]Choręziak-MichalakA, SzpechtD, Chmielarz-CzarnocińskaA, et al., 2023. Comprehensive analysis of the role of gene variants in matrix metalloproteinases and their tissue inhibitors in retinopathy of prematurity: a study in the Polish population. Int J Mol Sci, 24(20):15309.

[14]ConnorKM, KrahNM, DennisonRJ, et al., 2009. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc, 4(11):1565-1573.

[15]DammannO, HartnettME, StahlA, 2023. Retinopathy of prematurity. Dev Med Child Neurol, 65(5):625-631.

[16]DaruichA, Bremond-GignacD, Behar-CohenF, et al., 2020. Retinopathy of prematurity: from prevention to treatment. Med Sci (Paris), 36(10):900-907.

[17]de Carvalho SantuchiM, DutraMF, VagoJP, et al., 2019. Angiotensin-(1–7) and alamandine promote anti-inflammatory response in macrophages in vitro and in vivo. Mediators Inflamm, 2019:2401081.

[18]de JesusICG, ScalzoS, AlvesF, et al., 2018. Alamandine acts via MrgD to induce AMPK/NO activation against Ang II hypertrophy in cardiomyocytes. Am J Physiol Cell Physiol, 314(6):C702-C711.

[19]de JesusICG, MesquitaT, Souza SantosRA, et al., 2023. An overview of alamadine/MrgD signaling and its role in cardiomyocytes. Am J Physiol Cell Physiol, 324(3):C606-C613.

[20]DomińskaK, OkłaP, KowalskaK, et al., 2018. Angiotensin 1–7 modulates molecular and cellular processes central to the pathogenesis of prostate cancer. Sci Rep, 8:15772.

[21]DongLJ, LiWB, LinTT, et al., 2021. PSF functions as a repressor of hypoxia-induced angiogenesis by promoting mitochondrial function. Cell Commun Signal, 19:14.

[22]DuanYQ, BeliE, LiCalzi S, et al., 2018. Loss of angiotensin-converting enzyme 2 exacerbates diabetic retinopathy by promoting bone marrow dysfunction. Stem Cells, 36(9):1430-1440.

[23]Fevereiro-MartinsM, Marques-NevesC, GuimarãesH, et al., 2023. Retinopathy of prematurity: a review of pathophysiology and signaling pathways. Surv Ophthalmol, 68(2):175-210.

[24]GuoY, GuRP, GanDK, et al., 2020. Mitochondrial DNA drives noncanonical inflammation activation via cGAS-STING signaling pathway in retinal microvascular endothelial cells. Cell Commun Signal, 18:172.

[25]HartnettME, 2023. Pathophysiology of retinopathy of prematurity. Annu Rev Vis Sci, 9:39-70.

[26]HeXM, WenSY, TangXX, et al., 2024. Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling. Acta Pharm Sin B, 14(6):2613-2630.

[27]HuZZ, MaoXY, ChenMK, et al., 2022. Single-cell transcriptomics reveals novel role of microglia in fibrovascular membrane of proliferative diabetic retinopathy. Diabetes, 71(4):762-773.

[28]HuangH, 2020. Pericyte-endothelial interactions in the retinal microvasculature. Int J Mol Sci, 21(19):7413.

[29]KarlstetterM, ScholzR, RutarM, et al., 2015. Retinal microglia: just bystander or target for therapy? Prog Retin Eye Res, 45:30-57.

[30]LashkariK, HiroseT, YazdanyJ, et al., 2000. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol, 156(4):1337-1344.

[31]LautnerRQ, VillelaDC, Fraga-SilvaRA, et al., 2013. Discovery and characterization of alamandine: a novel component of the renin–angiotensin system. Circ Res, 112(8):1104-1111.

[32]LiHG, HorkeS, FörstermannU, 2014. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis, 237(1):208-219.

[33]LiN, GaoS, WangJ, et al., 2019. Anti-apoptotic effect of interleukin-17 in a mouse model of oxygen-induced retinopathy. Exp Eye Res, 187:107743.

[34]LiP, ChenXR, XuF, et al., 2018. Alamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways. Life Sci, 206:106-116.

[35]Mintz-HittnerHA, KennedyKA, ChuangAZ, 2011. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med, 364(7):603-615.

[36]MoravskiCJ, SkinnerSL, StubbsAJ, et al., 2003. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am J Pathol, 162(1):151-160.

[37]NicosiaRF, OttinettiA, 1990. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest, 63(1):115-122.

[38]ParkBM, PhuongHTA, YuLM, et al., 2018. Alamandine protects the heart against reperfusion injury via the MrgD receptor. Circ J, 82(10):2584-2593.

[39]PaulM, Poyan MehrA, KreutzR, 2006. Physiology of local renin-angiotensin systems. Physiol Rev, 86(3):747-803.

[40]PerelliRM, O'SullivanML, ZarnickS, et al., 2021. Environmental oxygen regulates astrocyte proliferation to guide angiogenesis during retinal development. Development, 148(9):dev199418.

[41]PhippsJA, DixonMA, JoblingAI, et al., 2019. The renin-angiotensin system and the retinal neurovascular unit: a role in vascular regulation and disease. Exp Eye Res, 187:107753.

[42]RathiS, JalaliS, PatnaikS, et al., 2017. Abnormal complement activation and inflammation in the pathogenesis of retinopathy of prematurity. Front Immunol, 8:1868.

[43]RattnerA, WilliamsJ, NathansJ, 2019. Roles of HIFs and VEGF in angiogenesis in the retina and brain. J Clin Invest, 129(9):3807-3820.

[44]RiveraJC, MadaanA, ZhouTE, et al., 2016. Review of the mechanisms and therapeutic avenues for retinal and choroidal vascular dysfunctions in retinopathy of prematurity. Acta Paediatr, 105(12):1421-1433.

[45]SabriK, EllsAL, LeeEY, et al., 2022. Retinopathy of prematurity: a global perspective and recent developments. Pediatrics, 150(3):e2021053924.

[46]SantiagoAR, MadeiraMH, BoiaR, et al., 2020. Keep an eye on adenosine: its role in retinal inflammation. Pharmacol Ther, 210:107513.

[47]SchleifenbaumJ, 2019. Alamandine and its receptor MrgD pair up to join the protective arm of the renin-angiotensin system. Front Med (Lausanne), 6:107.

[48]SongMA, DasguptaC, ZhangLB, 2015. Chronic losartan treatment up-regulates AT₁R and increases the heart vulnerability to acute onset of ischemia and reperfusion injury in male rats. PLoS ONE, 10(7):e0132712.

[49]Tual-ChalotS, AllinsonKR, FruttigerM, et al., 2013. Whole mount immunofluorescent staining of the neonatal mouse retina to investigate angiogenesis in vivo. J Vis Exp, (77):e50546.

[50]UemuraA, FruttigerM, D'AmorePA, et al., 2021. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res, 84:100954.

[51]ValléeA, GuillevinR, ValléeJN, 2018. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas. Rev Neurosci, 29(1):71-91.

[52]VoigtAP, MullinNK, StoneEM, et al., 2021. Single-cell RNA sequencing in vision research: insights into human retinal health and disease. Prog Retin Eye Res, 83:100934.

[53]WangYH, FangJW, NiuT, et al., 2023. Serum Ang-1/Ang-2 ratio may be a promising biomarker for evaluating severity of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol, 261(1):49-55.

[54]XuY, LuX, HuYG, et al., 2018. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice. J Pineal Res, 64(4):e12473.

[55]YangCX, WuXG, ShenYH, et al., 2020. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway. Eur J Pharmacol, 883:173384.

[56]YangXF, WangJP, ChenC, 2021. Serum VEGF and Ang-2 levels in infants before and after laser treatment for retinopathy of prematurity. Fetal Pediatr Pathol, 40(5):407-413.

[57]ZhangXZ, ZhangF, XuX, 2024. Single-cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy. Clin Transl Med, 14(7):e1751.

[58]ZhaoK, XuTH, MaoYK, et al., 2022a. Alamandine alleviated heart failure and fibrosis in myocardial infarction mice. Biol Direct, 17:25.

[59]ZhaoK, JiangYP, ZhangJ, et al., 2022b. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway. Cell Cycle, 21(19):2091-2108.

[60]ZhaoK, HuaDX, YangCX, et al., 2023. Nuclear import of Mas-related G protein-coupled receptor member D induces pathological cardiac remodeling. Cell Commun Signal, 21:181.

[61]ZhuP, VermaA, PrasadT, et al., 2020. Expression and function of Mas-related G protein-coupled receptor D and its ligand alamandine in retina. Mol Neurobiol, 57(1):513-527.

[62]ZimnaA, KurpiszM, 2015. Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. Biomed Res Int, 2015:549412.